Abstract
The keys to coping with the variability seen in SLE are accurate differentiation of active disease from past damage and consistent monitoring for new disease manifestations and medication side effects. Common clinical problems are reviewed.
MeSH terms
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Glucocorticoids / therapeutic use*
-
Humans
-
Kidney Diseases / complications
-
Lupus Erythematosus, Systemic / drug therapy*
-
Lupus Erythematosus, Systemic / mortality
-
Lupus Erythematosus, Systemic / physiopathology*
-
Prednisone / therapeutic use*
-
Prognosis
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Glucocorticoids
-
Prednisone